Liver Carcinoma clinical trials
60 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
- Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
- Jump: MR Simulation For Radiation Therapy Master Protocol
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- AMT-116 in Patients With Advanced Solid Tumors
- Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
- Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
- 4D-MRI for Precision Medicine
- Biobank for Cholestatic Liver Diseases.
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
- Sample Collection for Ongoing Research and Product Evaluation Study
- DESTINY-PANTUMOUR04
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- Liquid Biopsies in Pediatric Solid Tumors
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Blood Collection Biorepository for Liver Disease Research
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Integrated Cancer Repository for Cancer Research
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Collection of Blood From Patients With Cancer
- Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Feasibility Study of CBCT for IGRT in Cancer Patients
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Better Options for Chronic Cancer Pain
- Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
- A Study of CS231295 in Patients With Advanced Solid Tumors
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Liver Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.